hrcak mascot   Srce   HID

Izlaganje sa skupa

THE RELEVANCE OF NEGATIVE SYMPTOMS IN SCHIZOPHRENIA AND HOW TO TREAT THEM WITH PSYCHOPHARMACEUTICALS?

Puni tekst: engleski, pdf (80 KB) str. 435-440 preuzimanja: 85* citiraj
APA 6th Edition
(2016). THE RELEVANCE OF NEGATIVE SYMPTOMS IN SCHIZOPHRENIA AND HOW TO TREAT THEM WITH PSYCHOPHARMACEUTICALS?. Psychiatria Danubina, 28 (4), 435-440. Preuzeto s https://hrcak.srce.hr/177179
MLA 8th Edition
"THE RELEVANCE OF NEGATIVE SYMPTOMS IN SCHIZOPHRENIA AND HOW TO TREAT THEM WITH PSYCHOPHARMACEUTICALS?." Psychiatria Danubina, vol. 28, br. 4, 2016, str. 435-440. https://hrcak.srce.hr/177179. Citirano 30.03.2020.
Chicago 17th Edition
"THE RELEVANCE OF NEGATIVE SYMPTOMS IN SCHIZOPHRENIA AND HOW TO TREAT THEM WITH PSYCHOPHARMACEUTICALS?." Psychiatria Danubina 28, br. 4 (2016): 435-440. https://hrcak.srce.hr/177179
Harvard
(2016). 'THE RELEVANCE OF NEGATIVE SYMPTOMS IN SCHIZOPHRENIA AND HOW TO TREAT THEM WITH PSYCHOPHARMACEUTICALS?', Psychiatria Danubina, 28(4), str. 435-440. Preuzeto s: https://hrcak.srce.hr/177179 (Datum pristupa: 30.03.2020.)
Vancouver
THE RELEVANCE OF NEGATIVE SYMPTOMS IN SCHIZOPHRENIA AND HOW TO TREAT THEM WITH PSYCHOPHARMACEUTICALS?. Psychiatria Danubina [Internet]. 2016 [pristupljeno 30.03.2020.];28(4):435-440. Dostupno na: https://hrcak.srce.hr/177179
IEEE
"THE RELEVANCE OF NEGATIVE SYMPTOMS IN SCHIZOPHRENIA AND HOW TO TREAT THEM WITH PSYCHOPHARMACEUTICALS?", Psychiatria Danubina, vol.28, br. 4, str. 435-440, 2016. [Online]. Dostupno na: https://hrcak.srce.hr/177179. [Citirano: 30.03.2020.]
Puni tekst: njemački, pdf (80 KB) str. 435-440 preuzimanja: 275* citiraj
APA 6th Edition
(2016). THE RELEVANCE OF NEGATIVE SYMPTOMS IN SCHIZOPHRENIA AND HOW TO TREAT THEM WITH PSYCHOPHARMACEUTICALS?. Psychiatria Danubina, 28 (4), 435-440. Preuzeto s https://hrcak.srce.hr/177179
MLA 8th Edition
"THE RELEVANCE OF NEGATIVE SYMPTOMS IN SCHIZOPHRENIA AND HOW TO TREAT THEM WITH PSYCHOPHARMACEUTICALS?." Psychiatria Danubina, vol. 28, br. 4, 2016, str. 435-440. https://hrcak.srce.hr/177179. Citirano 30.03.2020.
Chicago 17th Edition
"THE RELEVANCE OF NEGATIVE SYMPTOMS IN SCHIZOPHRENIA AND HOW TO TREAT THEM WITH PSYCHOPHARMACEUTICALS?." Psychiatria Danubina 28, br. 4 (2016): 435-440. https://hrcak.srce.hr/177179
Harvard
(2016). 'THE RELEVANCE OF NEGATIVE SYMPTOMS IN SCHIZOPHRENIA AND HOW TO TREAT THEM WITH PSYCHOPHARMACEUTICALS?', Psychiatria Danubina, 28(4), str. 435-440. Preuzeto s: https://hrcak.srce.hr/177179 (Datum pristupa: 30.03.2020.)
Vancouver
THE RELEVANCE OF NEGATIVE SYMPTOMS IN SCHIZOPHRENIA AND HOW TO TREAT THEM WITH PSYCHOPHARMACEUTICALS?. Psychiatria Danubina [Internet]. 2016 [pristupljeno 30.03.2020.];28(4):435-440. Dostupno na: https://hrcak.srce.hr/177179
IEEE
"THE RELEVANCE OF NEGATIVE SYMPTOMS IN SCHIZOPHRENIA AND HOW TO TREAT THEM WITH PSYCHOPHARMACEUTICALS?", Psychiatria Danubina, vol.28, br. 4, str. 435-440, 2016. [Online]. Dostupno na: https://hrcak.srce.hr/177179. [Citirano: 30.03.2020.]

Sažetak
Negative symptoms are highly prevalent in the acute
episode and long-term course of schizophrenia. They are often
persistent and tend to chronicity. They have an important
negative impact on different dimensions of outcome and
therefore require careful diagnosis and treatment. However,
the evidence for the available psychopharmacological
treatments is still not satisfactory and further research is
needed.
Antipsychotics, especially some second-generation antipsychotics,
are the primary treatment of choice, particularly
for negative symptoms in the acute episode. In case of residual
negative symptoms concomitant treatment with antidepressants
is often indicated. Glutamatergic compounds are of
great theoretical interest as an add-on treatment or even as a
monotherapy, but so far the efficacy results are inconsistent
and their clinical use is limited.

Ključne riječi
negative symptoms; schizophrenia; antipsychotics; antidepressants; glutamatergic compounds

Hrčak ID: 177179

URI
https://hrcak.srce.hr/177179

[njemački]

Posjeta: 453 *